Skip to main content

Table 6 Demographic and clinical characteristics of PV patients

From: The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population

  GCC genotype  
  No (n= 10) Yes (n= 23) Pvalue
Age, mean (SD) 63.2 (12.4) 60.7 (14.0) 0.5779
Sex    
   Female 4 (40%) 13 (56.7%) 0.4646
   Male 6 (60%) 10 (43.5%)  
Splenomegaly 5/10 (50%) 12/23 (52.2%) 0.7413
Thrombosis 3/10 (30%) 4/20 (20%) 0.4786
Therapy requirement 9/10 (90%) 22/23 (95.7%) 0.2585
Cytogenetic abnormality 0/10 (0%) 3/23 (13%) 0.1781
MF evolution 3/10 (30%) 3/23 (13%) 0.0924
AML evolution 1/10 (10%) 3/23 (13%) 0.7614
Survival, median (SD) 3427 (2336) 2840 (2822) 0.7583
  1. P value is obtained from multivariate analysis.